Inactive Instrument
Immune Pharmaceuticals, Inc. Stock
Stocks
FZRQ
US45254C2008
Pharmaceuticals
OTC Markets Traded| 1 day | +300.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Devin J. Shaw
DFI | Director of Finance/CFO | 39 | 13/04/2021 |
John Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 11/12/2017 |
Boris Shor
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Sidransky
BRD | Director/Board Member | 66 | 26/08/2013 |
Daniel Kazado
CHM | Chairman | 61 | 10/10/2013 |
John A. Neczesny
BRD | Director/Board Member | 62 | 02/02/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03/02/20 | Sell | Director | 75,000 | 0.0412% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +300.00% | -.--% | - | - | 386K | |
| -1.12% | -5.49% | +60.19% | +112.43% | 1,060B | |
| -1.57% | -0.60% | +50.33% | +59.86% | 651B | |
| -1.81% | -1.41% | +24.07% | +75.98% | 465B | |
| -1.17% | -2.10% | +38.61% | +40.43% | 365B | |
| -2.00% | -1.35% | +22.22% | +38.92% | 300B | |
| -0.98% | +0.53% | +2.04% | +12.13% | 258B | |
| -0.76% | +0.75% | +51.75% | +70.45% | 238B | |
| -3.18% | -0.30% | -17.23% | -53.79% | 210B | |
| +0.52% | +3.78% | +30.67% | +93.68% | 184B | |
| Average | +28.79% | -0.07% | +29.18% | +50.01% | 414.49B | |
| Weighted average by Cap. | -1.36% | -1.46% | +38.43% | +65.86% |
Employees
7
Sector
Pharmaceuticals
